These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 36388804)

  • 1. Identification of ATP1B1, a key copy number driver gene in diffuse large B-cell lymphoma and potential target for drugs.
    Zhang S; Wang H; Liu A
    Ann Transl Med; 2022 Oct; 10(20):1136. PubMed ID: 36388804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agent Repurposing for the Treatment of Advanced Stage Diffuse Large B-Cell Lymphoma Based on Gene Expression and Network Perturbation Analysis.
    Xiang C; Ni H; Wang Z; Ji B; Wang B; Shi X; Wu W; Liu N; Gu Y; Ma D; Liu H
    Front Genet; 2021; 12():756784. PubMed ID: 34721544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of potential drugs for diffuse large b-cell lymphoma based on bioinformatics and Connectivity Map database.
    Luo B; Gu YY; Wang XD; Chen G; Peng ZG
    Pathol Res Pract; 2018 Nov; 214(11):1854-1867. PubMed ID: 30244948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Assessment of Necroptosis-Related Genes in Clinical Prognosis and Immune Cells in Diffuse Large B-Cell Lymphoma.
    Zhang Q; Zhu Z; Guan J; Zheng C
    Front Oncol; 2022; 12():904614. PubMed ID: 35814424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic and prognostic value of secreted protein acidic and rich in cysteine in the diffuse large B-cell lymphoma.
    Pan PJ; Liu JX
    World J Clin Cases; 2021 Aug; 9(22):6287-6299. PubMed ID: 34434995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
    Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
    Front Immunol; 2022; 13():950213. PubMed ID: 36072582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of hub genes associated with the pathogenesis of diffuse large B-cell lymphoma subtype one characterized by host response via integrated bioinformatic analyses.
    Zhou L; Ding L; Gong Y; Zhao J; Xin G; Zhou R; Zhang W
    PeerJ; 2020; 8():e10269. PubMed ID: 33240622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dark Side of Pyroptosis of Diffuse Large B-Cell Lymphoma in B-Cell Non-Hodgkin Lymphoma: Mediating the Specific Inflammatory Microenvironment.
    Wang W; Xu SW; Teng Y; Zhu M; Guo QY; Wang YW; Mao XL; Li SW; Luo WD
    Front Cell Dev Biol; 2021; 9():779123. PubMed ID: 34805183
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of estrogen receptor signaling pathway-related genes in diffuse large B-cell lymphoma and identification of key targets
    Chen B; Mao T; Qin X; Zhang W; Watanabe N; Li J
    Front Oncol; 2022; 12():1029998. PubMed ID: 36531013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma.
    Zheng W; Lin Q; Issah MA; Liao Z; Shen J
    BMC Cancer; 2021 Aug; 21(1):927. PubMed ID: 34404374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a five-gene signature associated with stromal infiltration for diffuse large B-cell lymphoma.
    Nan YY; Zhang WJ; Huang DH; Li QY; Shi Y; Yang T; Liang XP; Xiao CY; Guo BL; Xiang Y
    World J Clin Cases; 2021 Jun; 9(18):4585-4598. PubMed ID: 34222425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of potential key genes associated with diffuse large B-cell lymphoma based on microarray gene expression profiling.
    Luo X; Shi F; Qiu H; Tong Y; Gao X
    Neoplasma; 2017; 64(6):824-833. PubMed ID: 28895406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive characterization of driver genes in diffuse large B cell lymphoma.
    Fan Z; Pei R; Sha K; Chen L; Wang T; Lu Y
    Oncol Lett; 2020 Jul; 20(1):382-390. PubMed ID: 32565964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cuproptosis-related gene
    Xie J; Shao Z; Li C; Zeng C; Xu B
    Biomol Biomed; 2024 Jul; ():. PubMed ID: 39036924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of heterogeneous nuclear ribonucleoprotein as a candidate biomarker for diagnosis and prognosis of hepatocellular carcinoma.
    Du Y; Ma X; Wang D; Wang Y; Zhang T; Bai L; Liu Y; Chen S
    J Gastrointest Oncol; 2021 Oct; 12(5):2361-2376. PubMed ID: 34790398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and Significance of Cyclin-Dependent Protein Kinase 6 in Diffuse Large B-Cell Lymphoma.
    Li J; Li P; Su H; Feng H; Bai Z; Xi Y
    Int J Gen Med; 2022; 15():7265-7276. PubMed ID: 36133914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the molecular mechanisms and shared gene signatures between rheumatoid arthritis and diffuse large B cell lymphoma.
    Li H; Yu L; Zhang X; Shang J; Duan X
    Front Immunol; 2022; 13():1036239. PubMed ID: 36389761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identify the Molecular Target of Diffuse Large B Cell Lymphoma by Bioinformatics Analysis].
    Zhou Y; He S
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Oct; 28(5):1585-1591. PubMed ID: 33067958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Hub Genes and Pathways Associated with CAR-T Cell-Mediated Neurotoxicity in DLBCL.
    Wang Y; Li B; Wang Z; Li C; Bi G; Liu G; Teng Q; Guo D
    Clin Lab; 2021 Aug; 67(8):. PubMed ID: 34383407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated Genome-Wide Analysis of Gene Expression and DNA Copy Number Variations Highlights Stem Cell-Related Pathways in Small Cell Esophageal Carcinoma.
    Liu D; Xu X; Wen J; Xie L; Zhang J; Shen Y; Jiang G; Chen J; Fan M
    Stem Cells Int; 2018; 2018():3481783. PubMed ID: 30228821
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.